Medical Licensing (MD/DO) · Independent exam preparation
USMLE Step 1: Mechanisms, Clinical Clues, and Applied Reasoning Study Guide
Connect disease mechanisms to clinical clues, distinguish selected pathogens, interpret nutritional and laboratory patterns, and apply physiology and drug molecular targets across all 11 weighted Step 1 system categories.
By CertMedbry · Updated 18 October 2026
Practise diagnostic discrimination, molecular mechanisms, normal physiology, microbiology, pharmacology, nutritional interpretation, inheritance, screening calculations, and patient communication. These 60 selective concepts cover all 11 weighted Step 1 system categories without teaching every listed condition or discipline. The official USMLE content outline and Step 1 specifications define the full examination scope and emphasis: https://www.usmle.org/sites/default/files/2022-01/USMLE_Content_Outline_0.pdf and https://www.usmle.org/exam-resources/step-1-materials/step-1-content-outline-and-specifications. Use them to extend study beyond this focused guide.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and licensure pathway does this guide cover?
This guide covers the United States Medical Licensing Examination Step 1. USMLE contributes to physician licensure decisions in the United States and its territories; each medical licensing authority sets its own requirements. Step 2 CK and Step 3 are separate examinations. COMLEX-USA is a separate examination pathway. Historical NBME Parts examinations and FLEX preceded USMLE and are not alternate names for current Step 1.
What are the current examination duration and block structure?
For examinations on or after May 14, 2026, Step 1 has fourteen 30-minute blocks within one eight-hour session. Each block contains at most 20 questions. The examination includes at least 55 minutes of break time and an optional five-minute tutorial. Finishing blocks or the tutorial early can increase available break time.
How many questions are there, and how many are scored or pretest items?
The official software-transition announcement states that the overall 280-item total was retained. The current Step 1 page states that individual blocks may vary in question count but do not exceed 20 questions. These sources do not establish the number of scored versus unscored pretest items, so no numerical split is given here.
Test Delivery Software Updates for Step 2 CK and Step 1 Coming in May 2026 · Step 1
How is Step 1 delivered, and is adaptivity established?
Step 1 is administered at Prometric test centers using testing software and timed blocks. The cited official pages describe the block structure but do not establish an adaptive testing algorithm. Use the official interactive testing experience to become familiar with the current interface.
Step 1 · Test Delivery Software Updates for Step 2 CK and Step 1 Coming in May 2026
Which question styles should candidates prepare to interpret?
The official specifications describe multiple-choice questions. Most require application of basic science, including interpretation of graphs, tables, and gross or microscopic specimens. The 20 questions here are independent, four-option, single-best-answer drills. They do not reproduce the full examination interface, visual content, or item distribution and do not predict passing.
Which blueprint version applies, and what dates are verified?
The public content-outline PDF identifies itself internally as the 2026 outline despite its older URL directory. It is shared across the USMLE Steps; the live Step 1 specifications determine Step 1 emphasis. The specifications available on October 18, 2026 display no explicit revision or effective date. The companion tasks document carries copyright 2025. The software change has a verified effective date of May 14, 2026.
USMLE Content Outline (2026) · Step 1 Exam Content · USMLE Physician Tasks/Competencies · Test Delivery Software Updates for Step 2 CK and Step 1 Coming in May 2026
How are the official system weights represented?
The published ranges are Human Development 1–3%; Blood & Lymphoreticular/Immune Systems 9–13%; Behavioral Health & Nervous Systems/Special Senses 10–14%; Musculoskeletal, Skin & Subcutaneous Tissue 8–12%; Cardiovascular System 7–11%; Respiratory & Renal/Urinary Systems 11–15%; Gastrointestinal System 6–10%; Reproductive & Endocrine Systems 12–16%; Multisystem Processes & Disorders 8–12%; Biostatistics & Epidemiology/Population Health 4–6%; and Social Sciences: Communication and Interpersonal Skills 6–9%. These percentages may change. All categories are represented here, but selective allocation and whole-item rounding prevent exact replication of the official ranges.
How should competency and discipline percentages influence study?
The competency ranges are foundational science 60–70%, diagnosis 20–25%, communication 6–9%, and practice-based learning and improvement 4–6%. Discipline ranges are pathology 45–55%, physiology 30–40%, nutrition 15–20%, gross anatomy and embryology 10–20%, microbiology 10–20%, pharmacology 10–20%, behavioral sciences 10–15%, biochemistry 5–15%, histology and cell biology 5–15%, immunology 5–15%, and genetics 5–10%. Discipline classifications overlap, so their percentages exceed 100% when added. Combine mechanisms with diagnosis, pathogen identification, nutrient handling, drug action, and interpretation rather than studying each classification in isolation.
Step 1 assesses foundational medical science within the United States physician licensure pathway. It is one of three USMLE examinations. FSMB and NBME jointly own the program; individual medical boards grant licenses. This independently authored guide contains original learning exercises and is not an official or endorsed USMLE preparation product.
Outline used: USMLE Content Outline (2026), supplemented by the live Step 1 Content Specifications retrieved on 2026-10-09. The live specifications display no explicit revision or effective date. The linked Physician Tasks/Competencies document carries copyright 2025. The workbook label maps directly to the official Step 1 examination; the assigned slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Human Development1–3%
1.Which developmental findings require action at 18 months?
CDC milestones by 18 months include walking without holding on and trying to say at least three words besides “mama” or “dada.” Combining at least two words is a separate expectation by two years. Assess developmental domains individually. A missed milestone, loss of an acquired skill, or parental concern warrants discussion and developmental assessment when identified; an achieved motor milestone does not resolve a language concern.
Apply it
An 18-month-old walks independently but attempts only “mama,” “dada,” and one additional word. The language finding falls short of the stated milestone and should be addressed now rather than postponed until the two-year word-combination assessment.
Common pitfall: Do not use an unspecified “few words” to judge language development or wait for the next age milestone when a current concern is already present.
Blood & Lymphoreticular/Immune Systems9–13%
2.How does abnormal hemoglobin cause sickling?
Sickle cell disease results from pathogenic HBB variants that produce abnormal beta-globin. Hemoglobin S can assemble into rigid polymers when deoxygenated, distorting red cells and reducing their flexibility. These cells obstruct small vessels and break down prematurely. Polymerization explains episodic ischemic pain, while shortened red-cell survival explains chronic hemolytic anemia.
Apply it
A patient with sickle cell disease develops severe limb pain during reduced oxygenation. Connect deoxygenated hemoglobin polymerization to red-cell rigidity, impaired passage through small vessels, and reduced tissue perfusion. Baseline anemia between episodes reflects premature red-cell destruction.
Common pitfall: Do not explain sickling as deficient iron supply or require an acute fall in hemoglobin to explain every painful episode. Reduced oxygenation changes the behavior of abnormal hemoglobin already within circulating cells.
MedlinePlus Genetics: Sickle Cell Disease · Sickle Cell Disease - Causes and Risk Factors | NHLBI, NIH
3.How is sickle cell disease inherited?
Sickle cell disease follows an autosomal recessive inheritance pattern. An affected person inherits disease-associated HBB variants from both parents, although the variants need not be identical. Hemoglobin S combined with another clinically significant beta-globin variant can also produce disease. Two parents heterozygous for the same sickle variant have a one-in-four affected probability per pregnancy under the stated Mendelian assumptions.
Apply it
Each parent has one usual HBB allele and one hemoglobin S allele. Their next pregnancy has a 25% probability of two hemoglobin S alleles, independently of previous outcomes.
Common pitfall: Do not assume every affected person has two identical hemoglobin S alleles or that a previous unaffected child changes the next pregnancy’s probability.
4.How does altered penicillin-binding protein produce methicillin resistance in Staphylococcus aureus?
Beta-lactam antibiotics inhibit penicillin-binding proteins involved in bacterial cell-wall assembly. In a common MRSA mechanism, mecA encodes PBP2a, which has reduced affinity for many beta-lactams and permits cell-wall synthesis despite their presence. This is target alteration; beta-lactamase instead destroys the drug’s beta-lactam ring. See [CDC’s MRSA laboratory reference](https://www.cdc.gov/mrsa/php/laboratories/) and [FDA’s beta-lactam mechanism review](https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209776Orig1s000MedR.pdf).
Apply it
An S. aureus isolate is mecA-positive and produces PBP2a. Explain resistance through an altered drug target rather than assuming that a beta-lactamase inhibitor alone will restore activity.
Common pitfall: Do not equate every beta-lactam resistance mechanism with drug destruction or declare all beta-lactams inactive against MRSA; certain agents, including ceftaroline, retain activity.
5.What fails in the respiratory burst of chronic granulomatous disease?
Chronic granulomatous disease impairs the phagocyte NADPH oxidase complex. This complex generates superoxide, initiating production of reactive oxygen species used in microbial killing. Phagocytes may ingest organisms but fail to kill certain bacteria and fungi efficiently. CYBB-related disease is X-linked; defects in several other oxidase-component genes are autosomal recessive.
Apply it
A child has recurrent deep bacterial and fungal infections, an adequate neutrophil count, preserved organism ingestion, and markedly reduced oxidative-burst activity. Localize the defect to intracellular oxidative killing rather than cell abundance, tissue recruitment, or uptake.
Common pitfall: Do not infer normal antimicrobial function from a normal count or apply one inheritance model to every oxidase-component defect. The affected gene determines the relevant transmission pattern.
6.Which HIV replication steps distinguish reverse-transcriptase, integrase, and protease inhibitors?
HIV infects CD4 cells and uses reverse transcriptase to convert viral RNA into DNA. Integrase inserts viral DNA into host DNA. Viral protease cleaves protein precursors during maturation of newly formed particles. Reverse-transcriptase inhibitors, integrase inhibitors, and protease inhibitors therefore act at different viral enzyme targets. The [NIH HIV life-cycle reference](https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-life-cycle) links these steps to antiretroviral classes.
Apply it
A compound prevents insertion of HIV DNA into host DNA while leaving RNA-to-DNA synthesis intact. Its effect localizes to integration rather than reverse transcription. A drug preventing protein-precursor cleavage instead targets viral maturation.
Common pitfall: Do not confuse reverse transcription with integration or assume that suppressing viral replication removes every integrated viral DNA copy.
7.How do Aspergillus morphology, host susceptibility, and an azole target fit together?
Aspergillus can cause invasive infection in susceptible hosts, including patients with defective phagocyte killing. Tissue typically shows septate hyphae with acute-angle branching; vascular invasion can cause thrombosis, infarction, and necrosis. Voriconazole inhibits fungal lanosterol 14-alpha-demethylation, impairing ergosterol synthesis. Morphology and invasion are described in [CDC’s fungal disease reference](https://stacks.cdc.gov/view/cdc/222379/cdc_222379_DS1.pdf); the molecular target is described in [the manufacturer’s prescribing information](https://www.pfizermedicalinformation.com/vfend/clinical-pharmacology).
Apply it
A patient with an oxidative-burst defect develops a pulmonary lesion after exposure to decaying vegetation. Septate branching hyphae invading vessels support an invasive mold process and explain adjacent tissue infarction.
Common pitfall: Do not interpret fungal growth in a respiratory sample alone as proof of tissue invasion or treat acute-angle branching as sufficient to identify a particular Aspergillus species.
Behavioral Health & Nervous Systems/Special Senses10–14%
8.Which clinical pattern suggests Huntington disease?
Huntington disease produces progressive movement abnormalities, cognitive decline, and psychiatric or behavioral changes. Adult-onset disease commonly includes chorea. Progressive changes in planning or personality may precede obvious abnormal movements. A compatible illness in successive generations strengthens an autosomal dominant interpretation, but mood symptoms alone are nonspecific.
Apply it
A middle-aged adult develops involuntary movements, impaired financial planning, and irritability. A parent had a similar progressive illness. Integrate the neurological, cognitive, behavioral, and pedigree findings instead of treating each complaint as an unrelated diagnosis.
Common pitfall: Do not reduce Huntington disease to chorea or diagnose it from depression alone. Progression and the combined clinical pattern provide stronger discrimination than an isolated symptom.
9.How does repeat expansion produce Huntington anticipation?
Huntington disease results from expansion of a CAG repeat in HTT, producing an abnormally long glutamine segment in huntingtin. Repeat length can increase during transmission, and larger expansions generally associate with earlier onset. This intergenerational tendency is anticipation and occurs more often with paternal transmission. It changes expression without replacing the dominant inheritance model.
Apply it
An affected father has adult-onset disease, while his affected child has a larger repeat and much earlier onset. The unstable repeat explains the difference.
Common pitfall: Do not confuse anticipation with a change from dominant to recessive inheritance or assume repeat length predicts an exact onset date.
10.How can thyroid hormone excess resemble an anxiety disorder?
Thyrotoxicosis can cause nervousness, insomnia, tremor, and palpitations, overlapping with anxiety presentations. Persistent heat intolerance, weight loss, and objective thyroid abnormalities support a physiological contributor. Suppressed TSH with elevated thyroid hormone establishes a hormone-excess pattern but does not identify its source. Graves synthesis, destructive release, and excessive exogenous hormone remain distinct possibilities.
Apply it
A patient reporting new anxiety also has persistent tachycardia, heat intolerance, and weight loss. Elevated thyroid hormone and suppressed TSH connect the behavioral symptoms to thyrotoxicosis.
Common pitfall: Do not classify autonomic symptoms as a primary anxiety disorder solely from their emotional description or infer Graves disease from suppressed TSH alone.
NIDDK: Hyperthyroidism · Thyroiditis | American Thyroid Association · USMLE Content Outline (2026)
11.How does dopamine-neuron loss produce Parkinson motor symptoms?
Parkinson disease involves degeneration of dopamine-producing neurons in the substantia nigra, disrupting movement control. Typical findings include bradykinesia, rigidity, and often resting tremor. Constipation, impaired smell, sleep disturbance, depression, and cognitive changes can accompany the motor syndrome. These nonmotor symptoms broaden the clinical picture but are individually nonspecific.
Apply it
An older adult has progressive slowing, stiffness, and resting tremor without primary muscle weakness. Connect the pattern to impaired central dopaminergic signaling rather than failure of muscle force generation alone.
Common pitfall: Do not diagnose Parkinson disease from tremor, constipation, or reduced smell alone. Interpret these findings alongside movement abnormalities, progression, and the overall neurological examination.
MedlinePlus Genetics: Parkinson's Disease · Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease (U01) | PDBP
12.How do major depression, mania, and hypomania differ operationally?
A major depressive episode requires at least five symptom domains during the same two weeks, including depressed mood or anhedonia: depressed mood, anhedonia, appetite or weight change, insomnia or hypersomnia, psychomotor agitation or slowing, fatigue, worthlessness or excessive guilt, impaired concentration or indecision, and recurrent thoughts of death or suicide. Most symptoms occur nearly every day and represent a change from baseline, with significant distress or impairment. Mania requires elevated, expansive, or irritable mood plus increased energy or activity, present most of the day nearly every day for at least one week, or any duration if hospitalization is necessary. Require three associated symptoms, or four when mood is only irritable: grandiosity, decreased sleep need, pressured speech, racing thoughts or flight of ideas, distractibility, increased goal-directed activity or psychomotor agitation, and risky behavior. Mania causes marked impairment, requires hospitalization, or includes psychosis. Hypomania uses the same associated-symptom count but lasts at least four consecutive days, produces an observable change, and lacks marked impairment, hospitalization, and psychosis; psychosis makes the episode manic. Exclude direct substance, medication, and medical causes and consider psychotic-disorder explanations. See APA’s episode descriptions and symptom-count criteria.
Apply it
A patient needs little sleep, remains energetic, talks rapidly, reports exceptional abilities, and pursues risky projects. Establish duration and severity: four days with an observable change but preserved functioning can support hypomania; necessary hospitalization or psychosis supports mania. A depressive episode alone does not establish major depressive disorder until a history of mania or hypomania and other explanations have been assessed.
Common pitfall: Insomnia with fatigue differs from decreased need for sleep. Bipolar I requires a manic episode; bipolar II requires hypomania and a major depressive episode without a manic episode. Ordinary brief mood variation does not meet these episode definitions.
USMLE Content Outline (2026) · Psychiatry.org - What Are Bipolar Disorders? · bipolar.pdf
13.How should Parkinson disease family history be interpreted?
Most Parkinson disease does not follow a simple Mendelian pattern. Genetic susceptibility and environmental influences contribute, while some familial forms have dominant or recessive inheritance. A relative with Parkinson disease therefore does not establish a universal 50% recurrence risk. Variant transmission, penetrance, and clinical disease risk are separate quantities.
Apply it
A patient whose parent developed late-onset Parkinson disease asks whether every child has a one-in-two disease risk. That calculation requires an established dominant cause and an appropriate penetrance assumption.
Common pitfall: Do not transfer Huntington disease’s usual inheritance model to all neurodegenerative disorders. A shared clinical category does not establish a shared genetic mechanism.
MedlinePlus Genetics: Parkinson's Disease · MedlinePlus Genetics: Huntington's Disease
14.How do lens displacement, cataract, and glaucoma differ?
Lens displacement changes the position of an optical structure; cataract is clouding of that structure. Glaucoma concerns optic-nerve injury and is often associated with elevated intraocular pressure. These processes can all impair vision but localize differently. Marfan syndrome particularly associates with ectopia lentis and also increases the frequency of cataract and glaucoma.
Apply it
A patient with long limbs and aortic enlargement has visual disturbance and an off-center lens. The observed displacement supports ectopia lentis rather than cataract, which would require lens opacity.
Common pitfall: Do not treat every visual complaint in a connective-tissue disorder as the same lesion. Position, transparency, and optic-nerve findings answer different anatomical questions.
MedlinePlus Genetics: Marfan Syndrome · USMLE Content Outline (2026)
Musculoskeletal, Skin & Subcutaneous Tissue8–12%
15.What initiates joint destruction in rheumatoid arthritis?
Rheumatoid arthritis is an autoimmune disease targeting synovial tissue. The inflamed lining thickens through increased cellularity and protein production and can extend into cartilage and bone, causing structural damage. Symmetrical small-joint swelling and prolonged stiffness after rest support inflammatory synovitis. These tissue changes differ from simple mechanical wear.
Apply it
A patient has bilateral hand-joint swelling and prolonged morning stiffness. A tissue description of thickened, inflamed synovium explains how an initially inflammatory process can progress to damage of adjacent joint structures.
Common pitfall: Do not interpret joint pain alone as evidence of rheumatoid arthritis or mistake the synovial lesion for defective bone mineralization. Distribution, stiffness, swelling, and tissue findings supply the discriminating evidence.
16.How does allergic contact dermatitis differ from an immediate allergic reaction?
Allergic contact dermatitis is a delayed, T-cell-mediated response after sensitization to a contacting substance. Pruritic eczematous inflammation follows the exposure distribution and develops over hours to days. Immediate hypersensitivity instead involves IgE-triggered mast-cell mediator release and can produce rapid wheals or systemic manifestations. CDC distinguishes [delayed cell-mediated contact allergy from immediate IgE reactions](https://www.cdc.gov/vaccines/hcp/imz-best-practices/preventing-managing-adverse-reactions.html); [NIOSH describes allergic and irritant contact dermatitis](https://www.cdc.gov/niosh/skin-exposure/about/).
Apply it
An itchy eczematous eruption appears beneath a new metal watchband a day or two after exposure. The distribution and delay favor contact hypersensitivity over an immediate urticarial reaction.
Common pitfall: Do not assume every exposure-related rash is IgE-mediated. Irritant dermatitis can resemble allergy but results from direct injury and does not require antigen-specific sensitization.
17.Which microbiological findings distinguish Staphylococcus aureus from Streptococcus pyogenes in skin infection?
S. aureus typically forms gram-positive coccal clusters and is catalase-positive and coagulase-positive. S. pyogenes forms gram-positive coccal chains, is catalase-negative, and belongs to beta-hemolytic Lancefield group A. Purulent abscesses commonly suggest S. aureus, while diffuse nonpurulent cellulitis commonly suggests streptococci, but appearance alone does not establish the organism. See [CDC’s S. aureus case identification](https://wwwnc.cdc.gov/eid/article/12/1/05-0279_article), [group A streptococcal reference](https://stacks.cdc.gov/view/cdc/222379/cdc_222379_DS1.pdf), and [cellulitis guidance](https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/cellulitis.html).
Apply it
A draining lesion yields gram-positive cocci in clusters with positive catalase and coagulase tests. These findings identify S. aureus more specifically than the presence of pus alone. Group A beta-hemolytic cocci in chains support S. pyogenes instead.
Common pitfall: Catalase positivity alone does not establish S. aureus. Organism identification and antimicrobial susceptibility are separate questions; methicillin resistance requires appropriate resistance evidence.
18.What makes osteoporosis a bone-strength disorder?
Osteoporosis weakens bone through reduced bone mass and deterioration of bone structure, increasing susceptibility to fractures. It can remain silent until a fracture follows minor trauma. Common sites include the hip, spine, and wrist. The central abnormality is reduced structural strength rather than necessarily defective mineralization of the remaining bone.
Apply it
An older adult sustains a wrist fracture after a fall from standing height despite having no previous bone pain. The low-trauma mechanism makes skeletal fragility relevant even without earlier symptoms.
Common pitfall: Do not exclude osteoporosis because the patient previously felt well. Fragility can first become apparent through fracture, and pain intensity does not directly measure bone mass or strength.
19.Why does menopause increase osteoporosis risk?
Bone remodeling coordinates removal and formation. Estrogen helps maintain this balance, and declining estrogen after menopause accelerates bone loss. When removal exceeds replacement, bone mass and structural strength decline. This mechanism differs from insufficient mineralization of newly formed bone. Nutrition, medications, activity, and other conditions can modify the resulting fracture risk.
Apply it
A postmenopausal patient has declining bone mass despite apparently adequate calcium intake. Explain how hormonal changes can alter remodeling even when dietary mineral supply is sufficient.
Common pitfall: Do not assume adequate calcium intake eliminates osteoporosis risk or that every fracture reflects dietary calcium deficiency. Bone quantity, mineralization, and mechanical loading represent separate contributors to skeletal strength.
20.How does vitamin D deficiency differ from osteoporosis?
Vitamin D supports intestinal calcium absorption and calcium and phosphate availability for mineralization. Deficiency can produce rickets in children or osteomalacia in adults. Osteoporosis primarily reduces bone mass and structural strength. Both can cause fragility, but diffuse bone discomfort and a clear deficiency or malabsorption setting support a mineralization problem.
Apply it
An adult with chronic fat malabsorption, diffuse bone discomfort, and low 25-hydroxyvitamin D has evidence supporting osteomalacia rather than assuming uncomplicated osteoporosis.
Common pitfall: Do not use osteoporosis and osteomalacia interchangeably or assume that one excludes coexistence of the other. A fracture alone does not distinguish low bone quantity from impaired mineralization.
NIH Office of Dietary Supplements: Vitamin D—Health Professional Fact Sheet · NIAMS: Osteoporosis
Cardiovascular System7–11%
21.How does atherosclerotic narrowing produce demand-related ischemia?
Atherosclerotic plaque accumulates within arterial walls and can narrow the lumen. A restricted arterial supply may meet resting tissue needs but fail when oxygen demand rises. The symptomatic organ determines the vascular territory: coronary disease affects myocardium, while peripheral arterial disease can limit exercising leg muscles.
Apply it
Reproducible calf discomfort during walking that resolves with rest suggests a demand-related perfusion limitation in the leg’s arterial circulation. Walking increases muscle demand; rest reduces it without requiring the plaque itself to disappear.
Common pitfall: Do not equate a risk factor such as high cholesterol with demonstrated symptomatic obstruction or call all atherosclerosis coronary disease. Match the symptom pattern to the supplied tissue and arterial territory.
22.Why can plaque disruption produce abrupt ischemia?
Disruption of an atherosclerotic plaque exposes thrombogenic material to circulating blood. Platelet activation and coagulation can generate a local thrombus that rapidly restricts flow. This acute complication differs from gradual narrowing. Sudden symptoms at rest after a previously predictable exertional pattern support a new perfusion disturbance.
Apply it
A coronary specimen contains a disrupted plaque surface and a superimposed platelet-fibrin mass. Connect the exposed plaque to local thrombosis and abrupt flow reduction.
Common pitfall: Do not explain an abrupt occlusion solely through slow plaque growth or assume an embolus is required when the obstructing clot forms locally. An attached thrombus identifies a different process from a clot traveling from elsewhere.
23.How do valve stenosis and regurgitation alter flow?
Stenosis restricts forward passage through an open valve; regurgitation allows backward flow when the valve should be closed. Aortic regurgitation permits flow from the aorta into the left ventricle during diastole, adding a volume load. Mitral regurgitation permits left-ventricular flow into the left atrium during systole. Marfan-related connective-tissue abnormalities can cause valve leakage.
Apply it
Imaging shows blood returning from the aorta to the left ventricle during diastole in a patient with aortic-root enlargement. Identify aortic regurgitation rather than aortic stenosis.
Common pitfall: Do not name a valve lesion from “abnormal flow” alone. Identify direction, chamber relationship, and phase of the cardiac cycle.
MedlinePlus Genetics: Marfan Syndrome · USMLE Content Outline (2026)
24.How are stroke volume, ejection fraction, and cardiac output related?
Stroke volume equals end-diastolic volume minus end-systolic volume. Ejection fraction is stroke volume divided by end-diastolic volume. Cardiac output equals heart rate multiplied by stroke volume. These quantities describe different aspects of pump performance. In substantial valve regurgitation, total ventricular ejection includes backward flow, so it can exceed effective forward output. The [American Heart Association explains ejection fraction](https://www.heart.org/en/health-topics/heart-failure/diagnosing-heart-failure/ejection-fraction-heart-failure-measurement); the stroke-volume reference explains ventricular volumes and the regurgitation limitation.
Apply it
An end-diastolic volume of 120 mL and end-systolic volume of 50 mL give a stroke volume of 70 mL and ejection fraction of approximately 58.3%. At 70 beats/min without regurgitation, output is 4.9 L/min.
Common pitfall: Do not substitute ejection fraction for cardiac output or ignore the distinction between total and forward stroke volume in regurgitation.
USMLE Content Outline (2026) · CV Physiology | Regulation of Stroke Volume
25.How do preload, afterload, and contractility affect ventricular emptying?
Preload reflects ventricular filling and myocardial stretch before contraction. Afterload is the load opposing ejection. Contractility describes force generation at a given loading condition. Holding other variables constant, increased afterload impedes emptying and raises end-systolic volume; reduced contractility also leaves more blood after systole. Increased filling can augment stroke volume through the Frank-Starling mechanism within the physiological operating range.
Apply it
A sudden rise in arterial pressure increases the load against which the left ventricle ejects. If filling and contractility are unchanged, predict less complete emptying and reduced stroke volume.
Common pitfall: Do not treat preload, afterload, and contractility as synonyms. The immediate isolated effect of a loading change can differ from its later effect after compensatory changes in filling.
USMLE Content Outline (2026) · CV Physiology | Regulation of Stroke Volume
Respiratory & Renal/Urinary Systems11–15%
26.How does asthma produce variable airflow limitation?
Asthma usually involves chronic airway inflammation with variable expiratory airflow. Airway smooth-muscle contraction, wall swelling, and mucus narrow the lumen. Symptoms include episodic wheeze, cough, chest tightness, and breathlessness. Allergens, respiratory infections, exercise, smoke, and other irritants can trigger episodes, but asthma does not require one universal allergic mechanism.
Apply it
A patient wheezes after exercise or viral illness but feels well between episodes. Variable symptoms remain compatible with asthma, and objective evidence of variable expiratory airflow strengthens the diagnosis.
Common pitfall: Do not require continuous wheeze or a known allergy, and do not treat wheeze alone as diagnostic. A normal examination between episodes does not eliminate a variable airway disorder.
NHLBI: What Is Asthma? · GINA-Summary-Guide-2026-WEB-WMS.pdf
27.How do bronchodilators and inhaled corticosteroids address different asthma mechanisms?
Albuterol activates beta2-adrenergic receptors on airway smooth muscle, increasing adenylate cyclase activity and intracellular cyclic AMP, which promotes relaxation. Inhaled corticosteroids reduce airway inflammation and exacerbation risk. Immediate bronchodilation therefore does not establish control of the inflammatory disease. GINA recommends treatment containing inhaled corticosteroid for adults, adolescents, and children aged 6–11 years. The molecular bronchodilator pathway is described in [albuterol prescribing information](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=825975b1-a4a9-78ca-e053-2a91aa0a3948&type=display).
Apply it
A patient’s wheeze improves rapidly after albuterol. Link receptor activation to increased cyclic AMP and smooth-muscle relaxation, while recognizing the separate role of anti-inflammatory treatment in reducing future exacerbations.
Common pitfall: Do not equate transient symptom relief with correction of airway inflammation or apply a treatment recommendation without its age context.
28.How is an adult bronchodilator response calculated and interpreted?
GINA 2026 describes a positive adult spirometric bronchodilator response as an FEV1 or FVC increase of at least 12% and at least 200 mL from the pre-bronchodilator value. Percentage change is 100 × (post minus pre)/pre. Both conditions must be met. Responsiveness supports variable airflow in a compatible clinical setting; it does not independently establish asthma.
Apply it
FEV1 increases from 2.00 L to 2.30 L: the increase is 0.30 L, or 300 mL, and 0.30/2.00 × 100 = 15%. Both adult GINA conditions are satisfied.
Common pitfall: Do not use the post-bronchodilator value as the denominator. Criteria differ by age and testing standard, and a negative test on one occasion does not necessarily exclude asthma.
GINA-Summary-Guide-2026-WEB-WMS.pdf · NHLBI: Asthma Diagnosis
29.How does nephrotic protein loss produce edema?
Glomerular injury can permit excessive protein loss into urine. Albumin depletion lowers plasma oncotic pressure and favors tissue fluid accumulation. Renal sodium retention can also contribute. Heavy proteinuria, hypoalbuminemia, edema, and often hyperlipidemia form a nephrotic syndrome, which identifies a functional disturbance rather than one specific microscopic lesion.
Apply it
Marked urinary protein loss, low serum albumin, elevated cholesterol, and periorbital and ankle edema support a nephrotic syndrome. Demonstrated urinary loss explains reduced circulating albumin even when dietary protein intake is adequate.
Common pitfall: Do not infer the cause of edema from swelling alone, treat albumin as a specific test of intake, or mistake a syndrome for a histological diagnosis.
30.Why can nephrotic syndrome increase infection and clotting risks?
Glomerular protein loss extends beyond albumin. Loss of proteins involved in immune protection can increase infection susceptibility, while loss or imbalance of coagulation-regulating proteins contributes to thrombosis. Nephrotic syndrome therefore affects immunity and clotting as well as fluid distribution. These complications reflect the functions of the proteins lost, rather than edema mechanically causing every systemic problem.
Apply it
A patient with heavy proteinuria and edema develops a venous clot. The complication is compatible with altered coagulation regulation accompanying nephrotic protein loss.
Common pitfall: Do not assume urinary protein loss affects only oncotic pressure or that a renal disorder cannot produce a distant vascular complication. Infection and thrombosis require their own mechanistic explanations.
31.How do nitrofurantoin’s bacterial activation and distribution distinguish its role in urinary infection?
Bacterial enzymes, including flavoproteins, reduce nitrofurantoin to reactive intermediates that damage proteins, DNA, and other macromolecules. Its urinary antibacterial activity can address susceptible organisms such as Escherichia coli, but its limited tissue distribution makes it unsuitable for pyelonephritis or perinephric abscess. The [FDA prescribing information](https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009175Orig1s048lbl.pdf) distinguishes the mechanism, susceptible organisms, and anatomical limitation.
Apply it
A urine culture grows susceptible E. coli in a patient with bladder-localized symptoms. Contrast that setting with fever, flank pain, and renal infection: an organism’s in-vitro susceptibility does not establish adequate drug exposure within renal tissue.
Common pitfall: Do not infer treatment suitability from the organism name or urine susceptibility result alone. Antibacterial target, susceptibility, and concentration at the infected site are separate requirements.
32.Which clues support autosomal dominant polycystic kidney disease?
Autosomal dominant polycystic kidney disease commonly involves PKD1 or PKD2 variants and multiple renal cysts that can impair kidney function. Hypertension and cysts in other organs may accompany it. A compatible parent-child pattern supports dominant transmission, although manifestations vary. The combination of cyst distribution, associated findings, and family history is more informative than a single isolated cyst.
Apply it
An adult with bilateral renal cysts and hypertension has an affected parent and a pathogenic PKD1 variant. These findings support a dominant recurrence model and a shared inherited cause.
Common pitfall: Do not diagnose an inherited polycystic disorder from one incidental cyst or assume that relatives with the same variant must have identical severity.
33.How does recessive polycystic kidney disease differ from the dominant form?
Autosomal recessive polycystic kidney disease is associated with biallelic PKHD1 variants and often presents earlier than dominant disease. Hepatic abnormalities can accompany renal disease. Unaffected carrier parents can have an affected child; with two heterozygous carriers, the affected probability is 25% independently per pregnancy.
Apply it
An infant has cystic kidney disease and hepatic involvement, and both unaffected parents carry a PKHD1 variant. Apply recessive inheritance: the child inherited a disease-associated allele from each parent.
Common pitfall: Do not classify the disorder solely by age or exclude recessive disease because neither parent has the child’s phenotype. Molecular findings and inheritance clarify cases with overlapping clinical features.
Gastrointestinal System6–10%
34.How does gluten cause intestinal injury in celiac disease?
Transglutaminase 2 deamidates selected glutamine residues in gluten peptides to negatively charged glutamate residues. This improves presentation of relevant peptides through susceptible HLA-DQ2 or HLA-DQ8 molecules to gluten-reactive CD4 T cells. The resulting mucosal immune response contributes to epithelial injury, villous atrophy, crypt hyperplasia, and lymphocytic infiltration. Loss of absorptive surface contributes to malabsorption. For diagnosis, tTG-IgA is usually the preferred serologic test while the patient consumes gluten; interpret it with total IgA because IgA deficiency can produce a misleading negative result. Appropriate IgG-based tests are useful when IgA is deficient.
Apply it
A patient has chronic diarrhea, iron depletion, positive tTG-IgA with normal total IgA, and villous atrophy on duodenal biopsy. Connect modified gluten-peptide presentation to the intestinal T-cell response and reduced nutrient absorption. A positive HLA result indicates susceptibility and does not independently diagnose the disease.
Common pitfall: Do not treat celiac disease as an immediate wheat allergy or assume negative tTG-IgA excludes it when IgA is deficient or gluten has already been removed from the diet.
NIDDK: Definition and Facts for Celiac Disease · JCI - HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease · Celiac Disease Tests - NIDDK
35.How should anemia and poor growth be interpreted in a malabsorption case?
Adequate food intake does not guarantee nutrient absorption. Small-intestinal injury can contribute to anemia and impaired growth. Low ferritin supports depleted iron stores, while reduced red-cell size supports a microcytic anemia pattern. Inflammation can raise ferritin, so a normal or elevated value does not reliably exclude iron deficiency during inflammation. These findings identify a deficiency pattern but do not establish its cause; malabsorption and blood loss remain distinguishable explanations. See the [NIH ODS iron reference](https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/).
Apply it
A child has poor growth, chronic loose stools, microcytic anemia, and low ferritin despite adequate food access. The combination supports iron depletion with a possible intestinal cause rather than assuming insufficient calories alone.
Common pitfall: Do not use anemia as a synonym for iron deficiency, infer celiac disease from low ferritin alone, or treat ferritin as unaffected by inflammation.
NIDDK: Definition and Facts for Celiac Disease · USMLE Content Outline (2026)
36.Which vitamin D measurement best reflects nutritional status?
Serum 25-hydroxyvitamin D is the principal indicator of vitamin D status because it reflects dietary, supplemental, and skin-derived vitamin D and circulates longer than the active hormone. The active metabolite, 1,25-dihydroxyvitamin D, is tightly regulated and can remain normal until deficiency is severe. A normal active-hormone concentration therefore does not exclude depleted vitamin D availability.
Apply it
A patient with fat malabsorption has low 25-hydroxyvitamin D but normal 1,25-dihydroxyvitamin D. The normal active metabolite does not negate the low status marker.
Common pitfall: Do not substitute the active hormone for the status marker or apply one universal deficiency threshold without identifying the relevant standard.
NIH Office of Dietary Supplements: Vitamin D—Health Professional Fact Sheet
37.How does cystic fibrosis impair pancreatic digestion?
CFTR dysfunction alters epithelial salt and water transport and contributes to thick secretions. Pancreatic duct obstruction can prevent digestive enzymes from reaching the small intestine effectively. Adequate intake can therefore coexist with poor digestion, bulky stools, and inadequate weight gain. Fat malabsorption also threatens fat-soluble vitamin availability, including vitamin D needed for calcium absorption and mineralization.
Apply it
A child has recurrent respiratory infections, bulky stools, and poor growth despite a strong appetite. Pancreatic digestive failure explains the nutritional findings; low 25-hydroxyvitamin D can accompany impaired fat handling despite consumption of vitamin-containing foods.
Common pitfall: Do not assume every malabsorption syndrome begins in damaged intestinal mucosa or infer vitamin sufficiency from intake alone. Intake, digestion, absorption, and metabolism are separate steps.
MedlinePlus Genetics: Cystic Fibrosis · NIH Office of Dietary Supplements: Vitamin D—Health Professional Fact Sheet
38.How does cholera toxin produce profuse watery diarrhea without requiring villous destruction?
Cholera toxin ADP-ribosylates the stimulatory G-protein alpha subunit, Gsα. This modification impairs GTPase-mediated shutoff, prolonging the active GTP-bound state and sustaining adenylate cyclase activation. Increased intracellular cAMP activates protein kinase A and CFTR-mediated chloride secretion into the intestinal lumen; accompanying electrolyte and water movement produces profuse watery diarrhea. The toxin changes epithelial transport without requiring invasion or destruction of villi, so severe fluid loss can coexist with preserved intestinal architecture. The [original modification study](https://pubmed.ncbi.nlm.nih.gov/208069/) and [GTP-hydrolysis study](https://pmc.ncbi.nlm.nih.gov/articles/PMC431542/) explain the covalent modification and failed shutoff.
Apply it
After contaminated-water exposure, a patient develops abrupt profuse watery stools and dehydration without a destructive villous lesion. Trace the sequence from Gsα ADP-ribosylation and impaired GTP hydrolysis to sustained adenylate cyclase activity, increased cAMP, CFTR chloride secretion, and water loss. Preserved architecture is compatible with a functional secretory disturbance.
Common pitfall: Do not stop the mechanism at nonspecific G-protein activation or assume severe diarrhea requires mucosal destruction. Cholera toxin prolongs stimulatory Gsα signaling by impairing its shutoff; the resulting secretion differs from malabsorption caused by villous atrophy.
Reproductive & Endocrine Systems12–16%
39.How do antibodies stimulate hormone excess in Graves disease?
Graves disease causes hyperthyroidism through thyroid-stimulating immunoglobulins that bind and activate the TSH receptor. This receptor stimulation promotes thyroid hormone synthesis and secretion even when pituitary TSH is suppressed. Elevated thyroid hormone still exerts negative feedback on the pituitary, but that feedback does not remove the circulating stimulatory antibodies. Autoimmunity can therefore increase endocrine function through receptor activation.
Apply it
Elevated thyroid hormone, suppressed TSH, and thyroid-stimulating antibodies identify receptor-driven synthesis. Low measured TSH reflects appropriate pituitary feedback while the antibody supplies an independent stimulatory signal.
Common pitfall: Do not interpret low TSH as absence of all thyroid stimulation or assume all autoimmune endocrine disease causes deficiency. Destructive thyroiditis releases stored hormone through a different mechanism.
NIDDK: Graves' Disease · Thyroiditis | American Thyroid Association
40.How do thyrotoxicosis, hyperthyroidism, and TSH suppression differ?
Thyrotoxicosis means excess thyroid-hormone exposure. Hyperthyroidism specifically means increased synthesis and secretion by the thyroid gland. Graves disease produces both; destructive thyroiditis and excessive exogenous hormone can cause thyrotoxicosis without increased glandular synthesis. Suppressed TSH reflects negative feedback but does not distinguish these sources or prove that the excess originated within the thyroid.
Apply it
High free thyroid hormone with suppressed TSH establishes a thyrotoxic biochemical pattern. Additional clinical, antibody, exposure, or uptake information is needed to distinguish synthesis, destructive release, and exogenous hormone.
Common pitfall: Do not call every thyrotoxic state hyperthyroidism or localize the hormone source from TSH suppression alone.
NIDDK: Hyperthyroidism · Thyroiditis | American Thyroid Association
41.How does the source of thyrotoxicosis determine a drug’s target?
Destructive thyroiditis releases stored hormone from injured follicles; Graves disease drives new synthesis. Antithyroid medicines reduce synthesis and therefore address Graves hyperthyroidism but do not directly stop leakage of stored hormone. Beta blockers reduce manifestations such as tachycardia and tremor in thyrotoxicosis without establishing that hormone excess has resolved. Exogenous hormone also bypasses thyroid synthesis.
Apply it
A patient develops a painful thyroid followed by transient thyrotoxicosis and later hypothyroidism. Stored-hormone release explains why synthesis inhibition does not address the dominant initial source.
Common pitfall: Do not use symptomatic improvement as proof of biochemical correction or treat hormone release and hormone synthesis as the same process.
Thyroiditis | American Thyroid Association · NIDDK: Hyperthyroidism · NIDDK: Graves' Disease
42.How do ovarian hormones coordinate ovulation and endometrial changes?
FSH supports follicular development, and estradiol promotes endometrial proliferation. Sustained high estradiol near midcycle produces positive feedback that helps generate the LH surge and ovulation. The corpus luteum then produces progesterone, which supports a secretory endometrium. Without pregnancy, luteal regression and falling ovarian hormones lead to menstruation. See [NICHD’s ovarian-cycle explanation](https://www.nichd.nih.gov/newsroom/digital-media/infographics/ovulation-textalt) and the [human ovarian-hormone feedback experiment](https://pubmed.ncbi.nlm.nih.gov/479343/).
Apply it
A cycle shows an LH surge followed by increased progesterone. Interpret the sequence as ovulation followed by luteal activity rather than persistent follicular-phase physiology.
Common pitfall: Do not apply estrogen’s usual negative-feedback effect without recognizing the sustained preovulatory positive-feedback interval. Hormone interpretation depends on timing and sequence rather than an isolated concentration alone.
43.What distinguishes primary adrenal insufficiency?
Primary adrenal insufficiency originates in the adrenal glands. Cortisol is inadequate, and aldosterone may also be deficient. Loss of cortisol feedback raises ACTH and can accompany increased pigmentation. Aldosterone deficiency contributes to abnormal salt and potassium regulation and reduced circulating volume. These findings connect failure of the target gland to compensatory stimulation and mineralocorticoid consequences.
Apply it
Weight loss, low blood pressure, increased pigmentation, low cortisol, and high ACTH favor adrenal gland failure over isolated deficient pituitary stimulation.
Common pitfall: Do not localize adrenal insufficiency from cortisol alone. ACTH and mineralocorticoid-related findings add discriminating information, and low blood pressure by itself does not establish the anatomical cause.
NIDDK: Definition and Facts of Adrenal Insufficiency and Addison's Disease
44.How do secondary and tertiary adrenal insufficiency arise?
Secondary adrenal insufficiency reflects deficient pituitary ACTH; tertiary disease reflects deficient hypothalamic stimulation. Prolonged glucocorticoid exposure can suppress the axis, creating risk when treatment is abruptly withdrawn before recovery. Aldosterone is generally better preserved than in primary adrenal failure because its major regulation differs from cortisol’s dependence on ACTH.
Apply it
Weakness and low blood pressure after abrupt withdrawal of prolonged glucocorticoid treatment suggest suppression of the hypothalamic-pituitary-adrenal axis. The adrenal glands may lack adequate endogenous stimulation when the external glucocorticoid source disappears.
Common pitfall: Do not assume all adrenal insufficiency produces equivalent aldosterone loss or implies destruction of the adrenal glands. Distinguish deficient stimulation from primary target-gland failure.
NIDDK: Definition and Facts of Adrenal Insufficiency and Addison's Disease
45.What can an ACTH stimulation test establish?
An ACTH stimulation test evaluates adrenal cortisol responsiveness. An inadequate rise supports impaired reserve but does not always establish anatomical cause. Long-standing central ACTH deficiency can reduce adrenal responsiveness, while recent central deficiency may leave a relatively preserved response. Baseline ACTH and the duration of the illness are therefore essential interpretive clues.
Apply it
Low cortisol and a poor stimulation response in a patient with prolonged pituitary disease remain compatible with central adrenal insufficiency.
Common pitfall: Do not equate a failed response exclusively with primary adrenal destruction or a preserved response with exclusion of recent central disease. Functional reserve and the location of the original defect are separate questions.
NIDDK: Diagnosis of Adrenal Insufficiency and Addison's Disease
46.Which phenotype and signaling defect identify complete androgen insensitivity?
Complete androgen insensitivity classically combines 46,XY chromosomes, female-typical external genitalia, testes, an absent uterus, primary amenorrhea, and sparse pubic or axillary hair. Androgen normally binds AR, and the hormone-receptor complex regulates gene expression. Impaired receptor function prevents the expected tissue response despite androgen production. Testicular anti-Müllerian hormone signaling is distinct from androgen-receptor signaling.
Apply it
An adolescent with primary amenorrhea has female-typical external genitalia, little pubic hair, no uterus, and inguinal testes. This pattern supports androgen resistance rather than simply absent androgen synthesis.
Common pitfall: Do not infer normal hormone action from hormone availability or assume absent uterine development means that testes are absent.
MedlinePlus Genetics: Androgen Insensitivity Syndrome · USMLE Content Outline (2026)
Multisystem Processes & Disorders8–12%
47.How does fibrillin-1 dysfunction cause multisystem Marfan findings?
Marfan syndrome usually results from an FBN1 variant affecting fibrillin-1 and microfibrils. Altered connective-tissue support and growth-factor regulation affect the skeleton, eyes, and cardiovascular system. The usual inheritance is autosomal dominant, but new variants occur. Variable expression means that inheriting a variant does not predict identical severity across relatives.
Apply it
Long limbs, lens displacement, and aortic-root enlargement form a coherent connective-tissue pattern. A heterozygous affected parent has a one-in-two transmission probability under the stated model.
Common pitfall: Do not diagnose Marfan syndrome from height alone or use transmission probability as a precise prediction of organ involvement. A molecular inheritance calculation does not determine an individual’s vascular severity.
48.Why are aortic complications central in Marfan syndrome?
Abnormal connective tissue can weaken the aortic wall, permitting enlargement and increasing dissection or rupture risk. Aortic-root enlargement can also contribute to aortic valve leakage. Visible skeletal features do not measure the severity of the vascular component. Wall integrity and valve closure create distinct cardiovascular consequences of the same underlying connective-tissue disorder.
Apply it
A patient with mild skeletal manifestations has aortic enlargement. Explain why the less visible cardiovascular finding has consequences for both wall stability and effective valve closure, independent of apparent limb proportions.
Common pitfall: Do not judge cardiovascular involvement from the apparent mildness of the skeletal phenotype or assume that all affected organs express disease to the same degree.
49.How do liver and kidney function contribute to vitamin D activation?
Vitamin D from diet or skin undergoes hepatic hydroxylation to 25-hydroxyvitamin D and then primarily renal hydroxylation to active 1,25-dihydroxyvitamin D. Absorption failure, deficient substrate, and impaired activation are different mechanisms. Advanced renal dysfunction can impair active-hormone production even when dietary intake alone does not explain the problem.
Apply it
Compare low 25-hydroxyvitamin D in fat malabsorption with impaired active-hormone formation in advanced renal disease. The abnormalities occur at different steps in the same pathway.
Common pitfall: Do not assume dietary supplementation, measured vitamin status, and active-hormone production are interchangeable physiological quantities. An adequate supply of precursor does not establish normal conversion at every subsequent step.
NIH Office of Dietary Supplements: Vitamin D—Health Professional Fact Sheet
50.How does CFTR dysfunction connect lung and digestive disease?
CFTR encodes a chloride-transport protein in epithelial membranes. Dysfunction disrupts salt and water handling. Retained airway mucus promotes obstruction and infection, while pancreatic duct obstruction impairs digestive enzyme delivery. Cystic fibrosis follows autosomal recessive inheritance; two carrier parents have a 25% affected probability independently per pregnancy under the simple Mendelian model.
Apply it
Recurrent respiratory infections, thick secretions, poor growth, and pancreatic insufficiency support a shared epithelial transport mechanism. Unaffected carrier parents can have an affected child, and the inheritance probability does not predict that child’s severity.
Common pitfall: Do not infer a primary leukocyte defect solely from recurrent infection or exclude recessive disease because parents appear healthy. Abnormal physical clearance can predispose to infection.
51.Why is sweat unusually salty in cystic fibrosis?
CFTR dysfunction impairs salt reclamation in sweat ducts, increasing sweat salt content. This differs from the effects on secretions in the lungs and pancreas. The same transport protein has tissue-specific physiological roles, so one molecular defect need not produce identical secretion changes everywhere. Increased sweat salt reflects failed ductal recovery rather than requiring a separate disease.
Apply it
Salty sweat accompanying pulmonary disease and pancreatic insufficiency connects the findings through epithelial ion handling. Explain each manifestation using the normal transport role in that tissue.
Common pitfall: Do not explain every cystic-fibrosis manifestation through one identical mucus-concentration mechanism or infer that increased salt in sweat means all body secretions change in the same direction.
52.How do CFTR correctors and potentiators act at different molecular steps?
F508del-CFTR misfolding reduces processing and delivery of mature protein to the epithelial cell surface; the protein that arrives also has functional defects. Lumacaftor improves conformational stability, processing, and trafficking. Ivacaftor increases the channel-open probability of CFTR already at the surface. These are protein correction and potentiation, respectively, rather than replacement of the CFTR gene. See the [lumacaftor/ivacaftor prescribing information](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3fc1c40e-cfac-47a1-9e1a-61ead3570600&version=24).
Apply it
An experiment shows more mature CFTR at the membrane after one drug and increased opening of surface channels after another. Assign the first effect to correction of processing or trafficking and the second to potentiation of gating.
Common pitfall: Do not assume a gating potentiator can compensate for complete absence of surface protein or that every CFTR variant responds identically to a modulator.
Biostatistics & Epidemiology/Population Health4–6%
53.How do sensitivity and specificity use different denominators?
Sensitivity is TP/(TP+FN), the proportion of affected people testing positive. Specificity is TN/(TN+FP), the proportion of unaffected people testing negative. Disease status determines both denominators. Neither quantity is the probability that a particular positive or negative result correctly identifies an individual’s disease status.
Apply it
If 90 of 100 affected people test positive, sensitivity is 90%. If 180 of 200 unaffected people test negative, specificity is 90%. The remaining affected people are false negatives; the remaining unaffected people are false positives.
Common pitfall: Do not condition on test result when calculating sensitivity or specificity. Construct the two-by-two table first and identify the requested disease-status group before dividing.
54.Why does prevalence affect positive predictive value?
Positive predictive value is TP/(TP+FP). With sensitivity and specificity held constant, lower prevalence generally reduces positive predictive value because fewer affected people generate true positives while many unaffected people remain available to generate false positives. This is a population-dependent interpretation of a positive result.
Apply it
With 90 true positives and 99 false positives, positive predictive value is 90/189, approximately 47.6%. Although 90 affected people were detected, more than half of the positive results in this dataset are false positives.
Common pitfall: Do not assume high sensitivity and specificity guarantee high positive predictive value in a low-prevalence population. Predictive value conditions on the test result and therefore uses a different denominator.
55.How does participant selection affect interpretation of a diagnostic study?
A study comparing severe established cases with very healthy controls can overestimate diagnostic accuracy when intermediate cases and relevant competing conditions are omitted. Both sensitivity and specificity estimates depend on which patients are included, in addition to how disease status is established. FDA calls this spectrum bias and recommends representation of the intended-use population, including relevant disease states, confounding conditions, and demographic groups. See [FDA’s diagnostic-study guidance](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-guidance-reporting-results-studies-evaluating-diagnostic-tests-guidance-industry-and-fda).
Apply it
A biomarker separates advanced Parkinson disease from healthy volunteers. Correctly calculated performance in those groups does not establish accuracy among patients with early symptoms, other movement disorders, or relevant comorbidities.
Common pitfall: Do not confuse a correct calculation with validated clinical applicability. Examine the reference standard and participant spectrum before transferring sensitivity or specificity to a different population.
Social Sciences: Communication and Interpersonal Skills6–9%
56.How does teach-back reveal misunderstanding?
Teach-back asks a patient to explain important information in their own words. It checks how clearly the clinician communicated rather than testing intelligence. The patient’s account of the practical plan reveals misunderstandings that a nod or agreement may conceal. An open request produces observable evidence of comprehension because the patient must reconstruct the intended action.
Apply it
After explaining follow-up, ask the patient to describe what they will do at home and when they will return. Compare that explanation with the intended plan and clarify any mismatch.
Common pitfall: Do not treat a confident “yes” as demonstrated comprehension or ask the patient merely to repeat unfamiliar words without explaining their practical meaning.
57.When is demonstration better than verbal teach-back?
A physical skill requires an observable performance check. A patient may repeat instructions accurately while performing the sequence incorrectly. Ask for demonstration, identify the missed step, teach it again, and reassess the complete task. This distinguishes recall of verbal information from the ability to carry out an action in the intended order.
Apply it
After teaching a home device, ask the patient to show the sequence rather than merely naming its steps. If the sequence is incomplete, demonstrate the relevant step and observe another attempt.
Common pitfall: Do not accept memorized instructions as proof of procedural competence or assume that watching the clinician perform a task establishes that the patient can perform it independently.
58.How should unsuccessful teach-back change an explanation?
An inaccurate response identifies a communication gap. Use plain language, present less information at once, clarify the specific mismatch, and check again. Repeating the same complex explanation more loudly does not address unfamiliar vocabulary or an overloaded sequence. The revised explanation should directly target what the patient misunderstood.
Apply it
A patient confuses the follow-up schedule with the home-care instructions. Explain the schedule separately in simple terms and ask for another explanation before adding more information.
Common pitfall: Do not blame the patient or turn teach-back into an examination. The clinician’s task is to make the plan understandable and confirm that the revised explanation has corrected the practical misunderstanding.
59.Why use a qualified interpreter for important clinical discussions?
A qualified interpreter supports accurate and complete communication when language proficiency is insufficient for the discussion. Relatives may omit or filter information and create privacy concerns. Children should not carry responsibility for clinical interpretation. Language needs do not imply reduced intelligence or decision-making ability, and everyday conversational fluency may not support a complex medical discussion.
Apply it
A child offers to translate a complex discussion for a parent. Arrange qualified interpretation so the patient can participate directly, receive the full explanation, and express questions accurately.
Common pitfall: Do not equate familiarity with two languages with competence in medical interpretation or direct the discussion away from a patient who requires language assistance.
60.How should clinicians communicate through an interpreter?
Speak directly to the patient in clear, manageable segments and allow complete interpretation. Check comprehension through the patient’s own explanation or demonstration. Interpretation provides language access; teach-back separately assesses whether the intended practical meaning was understood. Both are necessary when accurate translation alone does not establish that a complex plan has been understood.
Apply it
Face the patient, explain one part of the plan, pause for interpretation, and ask the patient to describe the next action. Clarify any mismatch through the interpreter and check again.
Common pitfall: Do not direct care to the interpreter in the third person or assume translated words eliminate the need to check understanding. Preserve the patient’s direct participation throughout the discussion.
AHRQ: Address Language Differences—Tool 9 · AHRQ: Tool—Teach-Back
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Reconstruct causal chains from molecular or cellular defects to physiological changes, clinical findings, and discriminating evidence.
- Compare plausible diagnoses using time course, anatomy, tissue findings, hormone relationships, and measured functional responses.
- Distinguish selected bacterial, viral, and fungal mechanisms using organism features, host susceptibility, replication steps, and tissue injury.
- Connect drug molecular targets to their physiological effects, resistance mechanisms, tissue distribution, and variant-specific responses.
- Integrate nutrition through iron depletion, intestinal absorption, pancreatic digestion, protein loss, vitamin status markers, and hormone activation.
- Practise cardiac pump calculations, valve flow direction, reproductive feedback, receptor signaling, and developmental anatomy alongside disease mechanisms.
- Interpret tissue descriptions by identifying the affected structure and process, including synovial proliferation, plaque disruption, fungal invasion, and villous atrophy.
- Build two-by-two tables and examine study selection before applying diagnostic performance to a new population.
- Use teach-back, observed demonstration, and qualified interpretation as practical communication decisions.
- Extend this selective guide with the complete official outline and Step 1 specifications, including conditions and disciplines not developed here.
A practical preparation plan
1. Map the complete scope
Use the 2026 common outline alongside the live Step 1 system, competency, and discipline specifications. Track all 11 weighted categories and identify subjects absent from this selective guide.
2. Explain before naming
For each concept, identify the affected structure or signal, predict the physiological consequence, and name one finding that separates the closest alternative.
3. Connect pathogens and drug targets
For each selected infection, distinguish organism identification from host-defense failure. Then locate a drug’s molecular target, explain the relevant resistance mechanism, and determine whether drug exposure reaches the affected tissue.
4. Connect nutrition and normal physiology
Distinguish intake, digestion, absorption, loss, and activation. Work through cardiac volumes, ovarian feedback, receptor action, and nutritional laboratory patterns before linking them to disease.
5. Complete and review the drills
Answer all 20 questions independently. Classify errors as diagnostic discrimination, mechanism, localization, calculation, study interpretation, or communication. Explain why each competing option fails.
6. Use spaced recall
Revisit the flashcards over successive sessions and write a discriminating mini-case for missed concepts. Include the causal mechanism and one finding that would favor a competing diagnosis.
7. Broaden applied interpretation
Add basic-science problems involving actual graphs, laboratory tables, gross specimens, and histological images. This guide uses numerical and tissue descriptions rather than visual interpretation exercises. For each additional display, identify the measured variable or affected tissue before drawing a clinical conclusion.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- About the USMLE
- Step 1
- Step 1 Exam Content
- USMLE Content Outline (2026)
- USMLE Physician Tasks/Competencies
- Test Delivery Software Updates for Step 2 CK and Step 1 Coming in May 2026
- CDC: Milestones by 18 Months
- CDC: Milestones by 2 Years
- MedlinePlus Genetics: Sickle Cell Disease
- MedlinePlus Genetics: Chronic Granulomatous Disease
- MedlinePlus Genetics: Huntington's Disease
- MedlinePlus Genetics: Parkinson's Disease
- NIAMS: Rheumatoid Arthritis
- NIAMS: Osteoporosis
- NIH Office of Dietary Supplements: Vitamin D—Health Professional Fact Sheet
- NHLBI: Atherosclerosis
- NHLBI: What Is Asthma?
- NHLBI: Asthma Diagnosis
- MedlinePlus Genetics: Polycystic Kidney Disease
- NIDDK: Nephrotic Syndrome in Adults
- NIDDK: Definition and Facts for Celiac Disease
- NIDDK: Graves' Disease
- NIDDK: Hyperthyroidism
- NIDDK: Definition and Facts of Adrenal Insufficiency and Addison's Disease
- NIDDK: Diagnosis of Adrenal Insufficiency and Addison's Disease
- MedlinePlus Genetics: Androgen Insensitivity Syndrome
- MedlinePlus Genetics: Marfan Syndrome
- MedlinePlus Genetics: Cystic Fibrosis
- CDC Principles of Epidemiology: Lesson 5, Appendix A
- AHRQ: Tool—Teach-Back
- AHRQ: Address Language Differences—Tool 9
- Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease (U01) | PDBP
- GINA-Summary-Guide-2026-WEB-WMS.pdf
- Thyroiditis | American Thyroid Association
- Sickle Cell Disease - Causes and Risk Factors | NHLBI, NIH
- Psychiatry.org - What Are Bipolar Disorders?
- bipolar.pdf
- CV Physiology | Regulation of Stroke Volume
- Celiac Disease Tests - NIDDK
- JCI - HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease
- Hereditary spherocytosis: MedlinePlus Genetics
- Pyruvate kinase deficiency: MedlinePlus Genetics
- VFEND® (voriconazole) 12 CLINICAL PHARMACOLOGY | Pfizer Medical - US
- Community Case of Methicillin-resistant Staphylococcus aureus Infection - Volume 12, Number 1—January 2006 - Emerging Infectious Diseases journal - CDC
- These highlights do not include all the information needed to use Albuterol Sulfate HFA safely and effectively. See full prescribing information for Albuterol Sulfate HFA. Albuterol Sulfate HFA Inhalation Aerosol FOR ORAL INHALATION Initial U.S. Approval: 1981
- 009175Orig1s048lbl.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.